Aptar beats Q4 revenue, profit estimates; announces $600 mln buyback

Reuters02-06

<a href="https://laohu8.com/S/ATR">Aptar</a> beats Q4 revenue, profit estimates; announces $600 mln buyback

Overview

Drug delivery tech firm's Q4 revenue grew 14%, beating analyst expectations
Adjusted EPS for Q4 beat analyst expectations
Company announced new $600 mln share repurchase authorization

Outlook

Aptar expects Q1 2026 adjusted EPS between $1.13 and $1.21
Company anticipates strong Pharma growth outside emergency medicine
Aptar forecasts 2026 capital investments of $260 mln to $280 mln

Result Drivers

PHARMA GROWTH - Driven by strong demand for elastomeric components and systemic nasal drug delivery technologies
BEAUTY DEMAND - Double-digit growth in Beauty segment due to increased demand for dispensing technologies
PROFITABILITY IMPACT - Less favorable product mix and higher production costs affected overall profitability

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
Q4 Sales	Beat	$963 mln	$882.21 mln (6 Analysts)
Q4 Adjusted EPS	Beat	$1.25	$1.23 (7 Analysts)
Q4 EPS		$1.13
Q4 Net Income		$74.3 mln

Press Release: ID:nBw6JcRQka

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2609580828?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-06 06:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2609580828","market":"nz","top_or_hot":-1,"title":"Aptar beats Q4 revenue, profit estimates; announces $600 mln buyback","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title><a href=\"https://laohu8.com/S/ATR\">Aptar</a> beats Q4 revenue, profit estimates; announces $600 mln buyback</title></head><body><p><span>Overview</span></p><ul><li><p>Drug delivery tech firm's Q4 revenue grew 14%, beating analyst expectations</p></li><li><p>Adjusted EPS for Q4 beat analyst expectations</p></li><li><p>Company announced new $600 mln share repurchase authorization</p></li></ul><p><span>Outlook</span></p><ul><li><p>Aptar expects Q1 2026 adjusted EPS between $1.13 and $1.21</p></li><li><p>Company anticipates strong Pharma growth outside emergency medicine</p></li><li><p>Aptar forecasts 2026 capital investments of $260 mln to $280 mln</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>PHARMA GROWTH - Driven by strong demand for elastomeric components and systemic nasal drug delivery technologies</p></li><li><p>BEAUTY DEMAND - Double-digit growth in Beauty segment due to increased demand for dispensing technologies</p></li><li><p>PROFITABILITY IMPACT - Less favorable product mix and higher production costs affected overall profitability</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q4 Sales</p></td><td><p>Beat</p></td><td><p>$963 mln</p></td><td><p>$882.21 mln (6 Analysts)</p></td></tr><tr><td><p>Q4 Adjusted EPS</p></td><td><p>Beat</p></td><td><p>$1.25</p></td><td><p>$1.23 (7 Analysts)</p></td></tr><tr><td><p>Q4 EPS</p></td><td></td><td><p>$1.13</p></td><td></td></tr><tr><td><p>Q4 Net Income</p></td><td></td><td><p>$74.3 mln</p></td><td></td></tr></tbody></table><p>Press Release: <span>ID:nBw6JcRQka</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aptar beats Q4 revenue, profit estimates; announces $600 mln buyback</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAptar beats Q4 revenue, profit estimates; announces $600 mln buyback\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-06 06:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title><a href=\"https://laohu8.com/S/ATR\">Aptar</a> beats Q4 revenue, profit estimates; announces $600 mln buyback</title></head><body><p><span>Overview</span></p><ul><li><p>Drug delivery tech firm's Q4 revenue grew 14%, beating analyst expectations</p></li><li><p>Adjusted EPS for Q4 beat analyst expectations</p></li><li><p>Company announced new $600 mln share repurchase authorization</p></li></ul><p><span>Outlook</span></p><ul><li><p>Aptar expects Q1 2026 adjusted EPS between $1.13 and $1.21</p></li><li><p>Company anticipates strong Pharma growth outside emergency medicine</p></li><li><p>Aptar forecasts 2026 capital investments of $260 mln to $280 mln</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>PHARMA GROWTH - Driven by strong demand for elastomeric components and systemic nasal drug delivery technologies</p></li><li><p>BEAUTY DEMAND - Double-digit growth in Beauty segment due to increased demand for dispensing technologies</p></li><li><p>PROFITABILITY IMPACT - Less favorable product mix and higher production costs affected overall profitability</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q4 Sales</p></td><td><p>Beat</p></td><td><p>$963 mln</p></td><td><p>$882.21 mln (6 Analysts)</p></td></tr><tr><td><p>Q4 Adjusted EPS</p></td><td><p>Beat</p></td><td><p>$1.25</p></td><td><p>$1.23 (7 Analysts)</p></td></tr><tr><td><p>Q4 EPS</p></td><td></td><td><p>$1.13</p></td><td></td></tr><tr><td><p>Q4 Net Income</p></td><td></td><td><p>$74.3 mln</p></td><td></td></tr></tbody></table><p>Press Release: <span>ID:nBw6JcRQka</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ATR","symbol_name":"Aptar","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nL1N3Z11MG:1","article_id":"2609580828","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2609580828","pubTimestamp":1770329342,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Aptar beats Q4 revenue, profit estimates; announces $600 mln buybackOverviewDrug delivery tech firm's Q4 revenue grew 14%, beating analyst expectationsAdjusted EPS for Q4 beat analyst expectationsComp","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ATR":"Aptar","BK4126":"金属与玻璃容器"},"translate_title":"Aptar第四季度收入和利润超出预期；宣布6亿美元回购","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ATR":0.9},"content_text":"Aptar beats Q4 revenue, profit estimates; announces $600 mln buybackOverviewDrug delivery tech firm's Q4 revenue grew 14%, beating analyst expectationsAdjusted EPS for Q4 beat analyst expectationsCompany announced new $600 mln share repurchase authorizationOutlookAptar expects Q1 2026 adjusted EPS between $1.13 and $1.21Company anticipates strong Pharma growth outside emergency medicineAptar forecasts 2026 capital investments of $260 mln to $280 mlnResult DriversPHARMA GROWTH - Driven by strong demand for elastomeric components and systemic nasal drug delivery technologiesBEAUTY DEMAND - Double-digit growth in Beauty segment due to increased demand for dispensing technologiesPROFITABILITY IMPACT - Less favorable product mix and higher production costs affected overall profitabilityKey DetailsMetricBeat/MissActualConsensus EstimateQ4 SalesBeat$963 mln$882.21 mln (6 Analysts)Q4 Adjusted EPSBeat$1.25$1.23 (7 Analysts)Q4 EPS$1.13Q4 Net Income$74.3 mlnPress Release: ID:nBw6JcRQkaFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2609580828","isCrawlerRequest":true}